Cargando…

Clinical and echocardiographic characteristics of individuals aged 75/76 years old with screening-detected elevated NT-proBNP levels

BACKGROUND: High plasma levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) indicate increased probability of congestive heart failure (CHF) and atrial fibrillation (AF) and are associated with poor prognosis. OBJECTIVE: We aimed to describe the clinical and echocardiographic characteris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Khalili, Faris, Kemp-Gudmundsdottir, Katrin, Svennberg, Emma, Fredriksson, Tove, Frykman, Viveka, Friberg, Leif, Rosenqvist, Mårten, Engdahl, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Special Populations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046938/ https://www.ncbi.nlm.nih.gov/pubmed/32153793 http://dx.doi.org/10.1136/openhrt-2019-001200

Ejemplares similares

Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II study
por: Kemp Gudmundsdottir, Katrin, et al.
Publicado: (2020)

Brief episodes of rapid irregular atrial activity (micro-AF) are a risk marker for atrial fibrillation: a prospective cohort study
por: Fredriksson, Tove, et al.
Publicado: (2020)

Intermittent vs continuous electrocardiogram event recording for detection of atrial fibrillation—Compliance and ease of use in an ambulatory elderly population
por: Fredriksson, Tove, et al.
Publicado: (2020)

Performance of pulse palpation compared to one‐lead ECG in atrial fibrillation screening
por: Gudmundsdottir, Katrin Kemp, et al.
Publicado: (2021)

Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study
por: Lyth, Johan, et al.
Publicado: (2022)

Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023)

Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013)

Decentralising atrial fibrillation screening to overcome socio-demographic inequalities in uptake in STROKESTOP II
por: Gudmundsdottir, Katrin Kemp, et al.
Publicado: (2020)

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)

The Ability of Heart Failure Specialists to Accurately Predict NT-proBNP Levels Based on Clinical Assessment and a Previous NT-proBNP Measurement
por: Sedlak, Tara L, et al.
Publicado: (2008)

miR−21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation
por: Sieweke, Jan-Thorben, et al.
Publicado: (2020)

The impact of glutamate infusion on postoperative NT-proBNP in patients undergoing coronary artery bypass surgery: a randomized study
por: Jiang, Huiqi, et al.
Publicado: (2020)

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
por: Lewis, Robert A., et al.
Publicado: (2020)

Use of NT-proBNP in weaning from mechanical ventilation
por: Martini, A, et al.
Publicado: (2011)

NT-proBNP and the diagnosis of exercise-induced myocardial ischaemia
por: De Greef, Jacques, et al.
Publicado: (2008)

Rise and fall of NT-proBNP in aortic valve intervention
por: Hultkvist, Henrik, et al.
Publicado: (2018)

Highly sensitive detection of NT-proBNP by molecular motor
por: Zhang, Jie, et al.
Publicado: (2016)

In-hospital mortality is associated with high NT-proBNP level
por: Benmachiche, Malik, et al.
Publicado: (2018)

Admission NT-ProBNP in Myocardial Infarction: an Alert Sign?
por: da Silva, Luís Beck
Publicado: (2019)

The Potential Role of Salivary NT-proBNP in Heart Failure
por: Rammos, Aidonis, et al.
Publicado: (2023)

NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients
por: Reinhard, Henrik, et al.
Publicado: (2012)

Association of Paraoxonase-1 and NT-proBNP with Clinical, Clinico-Pathologic and Echocardiographic Variables in Dogs with Mitral Valve Disease
por: Rammal, Diana, et al.
Publicado: (2023)

Magnetic Resonance Detects Structural Heart Disease in Patients with Frequent Ventricular Ectopy and Normal Echocardiographic Findings
por: Scorza, Raffaele, et al.
Publicado: (2021)

BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine
por: Cao, Zhipeng, et al.
Publicado: (2019)

Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
por: Alawieh, Hussein, et al.
Publicado: (2019)

Does dipyridamole-induced ischaemia affect NT-proBNP secretion?
por: De Greef, Jacques, et al.
Publicado: (2007)

Using NT-proBNP as a criterion for heart failure hospitalization
por: Tamizifar, Babak, et al.
Publicado: (2012)

NT-proBNP in Children With Left to Right Shunt and Dilated Cardiomyopathy
por: Koura, Hala Mahmoud, et al.
Publicado: (2016)

The relationship between NT-proBNP and Depression in Patients with Heart Failure
por: Gao, Ying–Hui, et al.
Publicado: (2017)

NT-proBNP as a biomarker for hyperdynamic circulation in decompensated cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2018)

NT-proBNP and postoperative heart failure in surgery for aortic stenosis
por: Jiang, Huiqi, et al.
Publicado: (2019)

Significance of NT-proBNP and High-Sensitivity Troponin in Friedreich Ataxia
por: Legrand, Lise, et al.
Publicado: (2020)

Prognostic value of NT-proBNP in patients with severe COVID-19
por: Gao, Lei, et al.
Publicado: (2020)

Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
por: Lau, Chin-Shern, et al.
Publicado: (2022)

LSPR-Based Aptasensor for Rapid Urinary Detection of NT-proBNP
por: António, Maria, et al.
Publicado: (2023)

Utility of NT-proBNP as an objective marker of postoperative heart failure after coronary artery bypass surgery: a prospective observational study
por: Jiang, Huiqi, et al.
Publicado: (2021)

A comparison of the prognostic value of BNP versus NT-proBNP after hospitalisation for heart failure
por: Linssen, G. C. M., et al.
Publicado: (2018)

NT-proBNP levels in the ICU do not predict the etiology of respiratory distress
por: Mailloux, P, et al.
Publicado: (2006)

NT-ProBNP Levels in Saliva and Its Clinical Relevance to Heart Failure
por: Foo, Jared Yong Yang, et al.
Publicado: (2012)

NT-proBNP: A Guide to Improve the Management of Patients with Heart Failure
por: Latini, Roberto, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_90u4ev9arvbu26gu7599gkc9o7